Please Wait
Applying Filters...

Annual Sales of Pirfenidone reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 512Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Esbriet

02 5Pirespa

PharmaCompass

01

Brand Name : Pirespa

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Pirespa

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 58

2018 Revenue in Millions : 56

Growth (%) : 3

blank

02

Brand Name : Esbriet

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Esbriet

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Immunology

Currency : USD

2019 Revenue in Millions : 1,163

2018 Revenue in Millions : 1,062

Growth (%) : 10

blank

03

Brand Name : Pirespa

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Pirespa

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 55

2019 Revenue in Millions : 59

Growth (%) : -6

blank

04

Brand Name : Esbriet

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Esbriet

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 1,235

2019 Revenue in Millions : 1,258

Growth (%) : -2

blank

05

Brand Name : Esbriet

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Esbriet

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 1,118

2020 Revenue in Millions : 1,174

Growth (%) : -6

blank

06

Brand Name : Pirespa

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Pirespa

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 35

2020 Revenue in Millions : 53

Growth (%) : -28

blank

07

Brand Name : Esbriet

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Esbriet

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 785

2021 Revenue in Millions : 1,118

Growth (%) : -30

blank

08

Brand Name : Pirespa

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Pirespa

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 22

2021 Revenue in Millions : 35

Growth (%) : -39

blank

09

Brand Name : Esbriet

Pirfenidone

arrow
AAPS 2024
Not Confirmed

10

Brand Name : Pirespa

Pirfenidone

arrow
AAPS 2024
Not Confirmed

Brand Name : Pirespa

arrow
AAPS 2024
Not Confirmed

Pirfenidone

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 14

2022 Revenue in Millions : 22

Growth (%) : -25

blank